miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2

MLA

Dongming Yan, et al. “MiR-126-3p Sensitizes Glioblastoma Cells to Temozolomide by Inactivating Wnt/β-Catenin Signaling via Targeting SOX2.” Life Sciences, vol. 226, June 2019, pp. 98–106. EBSCOhost, https://doi.org/10.1016/j.lfs.2019.04.023.

APA

Dongming Yan, Wenzheng Luo, Xueyuan Li, Zhenyu Song, Shanshan Zhao, Xuqiang Zhu, & Xianzhi Liu. (2019). miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2. Life Sciences, 226, 98–106. https://doi.org/10.1016/j.lfs.2019.04.023

Chicago

Dongming Yan, Wenzheng Luo, Xueyuan Li, Zhenyu Song, Shanshan Zhao, Xuqiang Zhu, and Xianzhi Liu. 2019. “MiR-126-3p Sensitizes Glioblastoma Cells to Temozolomide by Inactivating Wnt/β-Catenin Signaling via Targeting SOX2.” Life Sciences 226 (June): 98–106. doi:10.1016/j.lfs.2019.04.023.